Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Juloori · SciRah

Researcher profile · Semantic Scholar

A. Juloori

Share profile

A. Juloori — researcher profile on SciRah

h-index: 14
Works: 84
Citations: 740

Most-cited papers

A Phase I Trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study).
C. Bestvina, K. Pointer, T. Karrison, H. Al-Hallaq +11 more
2021Journal of Thoracic Oncology99 citations Open access
Semantic Scholar
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer
S. Gutiontov, W. Turchan, L. Spurr, S. Rouhani +17 more
2021Scientific Reports90 citations Open access
Semantic Scholar
The oligometastatic spectrum in the era of improved detection and modern systemic therapy
R. Katipally, S. Pitroda, A. Juloori, S. Chmura +1 more
2022Nature Reviews Clinical Oncology77 citations
Semantic Scholar
Phase I Randomized Trial of Stereotactic Body Radiotherapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma.
A. Juloori, R. Katipally, J. Lemons, Ashutosh Kumar Singh +11 more
2022International Journal of Radiation Oncology, Biology, Physics59 citations
Semantic Scholar
Two-Dimensional Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy
Taokun Luo, Geoffrey T. Nash, Xiao-Min Jiang, Xuanyu Feng +5 more
2022Advances in Materials58 citations Open access
Semantic Scholar
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Clinical Trial.
A. Rosenberg, Nishant Agrawal, A. Juloori, J. Cursio +17 more
2024JAMA Oncology53 citations Open access
Semantic Scholar
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial.
A. Rosenberg, A. Juloori, M. Jelinek, Nishant Agrawal +13 more
2025JAMA Oncology33 citations Open access
Semantic Scholar
A phase 1 dose-escalation study of RiMO-301 with palliative radiation in advanced tumors.
M. Koshy, M. Spiotto, L. Feldman, J. Luke +16 more
2023Journal of Clinical Oncology30 citations
Semantic Scholar
Risk and Response Adapted De-Intensified Treatment for HPV-Associated Oropharyngeal Cancer: OPTIMA Paradigm Expanded Experience.
A. Rosenberg, N. Agrawal, A. Pearson, Z. Gooi +14 more
2021Oral Oncology28 citations Open access
Semantic Scholar
Nivolumab, nabpaclitaxel, and carboplatin followed by risk/response adaptive de-escalated locoregional therapy for HPV-associated oropharyngeal cancer: OPTIMA II trial.
A. Rosenberg, N. Agrawal, A. Pearson, T. Seiwert +10 more
202124 citations
Semantic Scholar
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
Thomas F. Cyberski, Alka Singh, Michael Korzinkin, Vasudha Mishra +18 more
2024npj Precision Oncology19 citations Open access
Semantic Scholar
Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma.
M. Sajisevi, Kenny Nguyen, Peter Callas, Andrew J. Holcomb +80 more
2023JAMA Otolaryngology - Head and Neck Surgery19 citations
Semantic Scholar
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiotherapy and Immunotherapy.
M. Korpics, R. Katipally, J. Partouche, D. Cutright +7 more
2022International Journal of Radiation Oncology, Biology, Physics16 citations
Semantic Scholar
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment
A. Rosenberg, E. Izumchenko, A. Pearson, Z. Gooi +15 more
2022BMC Cancer15 citations Open access
Semantic Scholar
Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas
Hanna M. Hieromnimon, A. Trzcinska, Frank T. Wen, F. M. Howard +20 more
2025Oral Oncology11 citations Open access
Semantic Scholar
Neoadjuvant HPV16-specific arenavirus-based immunotherapy HB-200 plus chemotherapy followed by response-stratified de-intensification in HPV16+ oropharyngeal cancer: TARGET-HPV.
A. Rosenberg, A. Juloori, E. Izumchenko, J. Cursio +15 more
2024Journal of Clinical Oncology10 citations
Semantic Scholar
Neoadjuvant nivolumab, paclitaxel, and carboplatin followed by response-stratified chemoradiation in locoregionally advanced HPV negative head and neck squamous cell carcinoma (HNSCC): The DEPEND trial.
A. Rosenberg, A. Juloori, N. Agrawal, J. Cursio +13 more
2023Journal of Clinical Oncology9 citations Open access
Semantic Scholar
Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal Carcinoma
Vivek Nair, Samuel R. Auger, S. Kochanny, Frederick M. Howard +10 more
2022JAMA Network Open9 citations Open access
Semantic Scholar
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials.
C. Lynch, M. Korpics, R. Katipally, C. Bestvina +5 more
2024European Journal of Cancer8 citations Open access
Semantic Scholar
Randomized phase I trial to evaluate Concurrent or Sequential Ipilimumab, Nivolumab, and stereotactic body Radiotherapy in patients with stage IV non-small cell lung cancer (COSINR Study).
J. Patel, C. Bestvina, T. Karrison, M. Jelinek +6 more
20208 citations
Semantic Scholar
Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma
A. Rosenberg, N. Agrawal, A. Pearson, Z. Gooi +12 more
2022British Journal of Cancer7 citations Open access
Semantic Scholar
Rationale for Investigation of Neoadjuvant Chemoimmunotherapy Before Chemoradiation in Unresectable Stage III Non-Small Cell Lung Cancer.
R. Thawani, C. Bestvina, E. Vokes, A. Juloori
2025Journal of Clinical Oncology6 citations
Semantic Scholar
Combined stereotactic body radiotherapy and immune checkpoint inhibition for liver metastases: safety and outcomes in a pooled analysis of three phase I trials.
C. Lynch, M. Korpics, R. Katipally, Tian-Ming Wu +4 more
2024International Journal of Radiation Oncology, Biology, Physics5 citations
Semantic Scholar
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non–Small-Cell Lung Cancer
R. Katipally, L. Spurr, S. Gutiontov, W. Turchan +18 more
2023JCO Precision Oncology5 citations Open access
Semantic Scholar
Safety and Efficacy of a Randomized Phase I Trial to Evaluate Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-small Cell Lung Cancer (COSINR Study)
S. Chmura, C. Bestvina, T. Karrison, M. Jelinek +12 more
20205 citations Open access
Semantic Scholar
Phase I Study of Stereotactic Body Radiotherapy followed by Ipilimumab with Nivolumab vs. Nivolumab alone in Unresectable Hepatocellular Carcinoma
A. Juloori, C.-Y. Liao, J. Lemons, A. Singh +8 more
20205 citations
Semantic Scholar
Early signs of efficacy in patients with anti-PD-1 naïve and anti-PD-1 resistant HNSCC treated with NBTXR3/SBRT in combination with nivolumab or pembrolizumab in the phase I trial Study 1100.
Colette J. Shen, J. Frakes, Trevor G. Hackman, J. Niu +12 more
2024Journal of Clinical Oncology4 citations Open access
Semantic Scholar
OA22.03 The Addition of Multisite SBRT to Ipilimumab and Nivolumab in First Line Metastatic NSCLC: The COSINR Trial
A. Juloori, C. Bestvina, K. Pointer, S. Pitroda +13 more
2023Journal of Thoracic Oncology4 citations Open access
Semantic Scholar
DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer.
C. Bestvina, Jared H L Hara, T. Karrison, Benjamen Bowar +11 more
2024Clinical Lung Cancer2 citations Open access
Semantic Scholar
Definitive Chemoradiotherapy for Salivary Gland Cancers.
G. Rajeev-Kumar, J. Hara, A. Rosenberg, A. Pearson +6 more
2023International Journal of Radiation Oncology, Biology, Physics2 citations
Semantic Scholar
Dares: A phase II trial of durvalumab and ablative radiation in extensive stage small cell lung cancer.
A. Juloori, G. Gan, Jun Zhang, M. Abazeed +8 more
2023Journal of Clinical Oncology2 citations Open access
Semantic Scholar
886P Prospective evaluation of dynamic changes of cell-free HPV-DNA (cfHPV-DNA) in locoregional HPV associated (HPV+) oropharyngeal cancer (OPC) treated with neoadjuvant chemotherapy and response-stratified treatment
A. Rosenberg, E. Izumchenko, A. Juloori, Z. Gooi +12 more
2023Annals of Oncology2 citations Open access
Semantic Scholar
Assessment of Tumor Burden and Response by RECIST vs. Volume Change in HPV+ Oropharyngeal Cancer – An Exploratory Analysis of Prospective Trials
M. Arshad, J. Hara, A. Rosenberg, D. Ginat +9 more
2022International Journal of Radiation Oncology, Biology, Physics2 citations Open access
Semantic Scholar
Clinical Factors Associated with Radionecrosis Following Stereotactic Radiosurgery in the Era of Modern Systemic Therapy
A. Sivananthan, M. Korpics, R. Katipally, T. Pathmarajah +6 more
2022International Journal of Radiation Oncology, Biology, Physics2 citations
Semantic Scholar
Functional and survival outcomes in HPV positive oropharyngeal squamous cell cancer treated with response-adaptive de-escalation: A pooled analysis.
Faith Abodunrin, J. Cursio, A. Juloori, N. Omenuko +8 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Delays in phases of care from identification to treatment of suspicious lung nodules
Nihar Rama, Rachel Nordgren, Aliya N. Husain, A. Juloori +11 more
2025JTCVS Open1 citations
Semantic Scholar
Phase I Dose Escalation/Dose Expansion Trial of NBTXR3/SBRT in Combination with Nivolumab or Pembrolizumab for the Treatment of anti-PD-1 Naïve or Resistant Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
C. Shen, A. Sukari, W. Stokes, G.-Q. Yang +15 more
2025International Journal of Radiation Oncology, Biology, Physics1 citations
Semantic Scholar
Circulating tumor HPV-DNA dynamics and neoadjuvant chemotherapy with or without nivolumab in viral-mediated oropharyngeal cancer.
Maha A. T. Elsebaie, E. Izumchenko, A. Juloori, R. Katipally +14 more
2025Journal of Clinical Oncology1 citations Open access
Semantic Scholar
To Test and Preserve the Trachea.
G. Rajeev-Kumar, A. Juloori
2024International Journal of Radiation Oncology, Biology, Physics1 citations
Semantic Scholar
Xevinapant with radiation and concurrent carboplatin and paclitaxel in patients ineligible for cisplatin with locoregionally advanced squamous cell carcinoma of the head and neck (EXtRaCT study).
Nabiel A. Mir, A. Juloori, P. Swiecicki, R. Katipally +6 more
2024Journal of Clinical Oncology1 citations
Semantic Scholar
185 Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer
A. Juloori, A. Rosenberg, Daniel Huang, N. Agrawal +9 more
2024Radiotherapy and Oncology1 citations Open access
Semantic Scholar
Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer.
D. Huang, A. Rosenberg, N. Agrawal, A. Pearson +9 more
2023International Journal of Radiation Oncology, Biology, Physics1 citations
Semantic Scholar
Randomized phase I/II trial of TheraT vectors expressing HPV16 specific antigens with neoadjuvant chemotherapy followed by transoral robotic surgery (TORS) or risk/response stratified chemoradiotherapy (CRT) for locoregional HPV16+ oropharyngeal cancer (OPC).
A. Rosenberg, N. Agrawal, A. Juloori, T. Karrison +8 more
2023Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Characterizing Lymph Node Burden With Elective Unilateral Neck Irradiation in Human Papillomavirus-Positive Tonsil Squamous Cell Carcinoma: Defining the Upper Limits
J. Hara, S. Gutiontov, Sophia Uddin, A. Rosenberg +8 more
2022Cureus1 citations Open access
Semantic Scholar
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio Following Combination Immunotherapy and Stereotactic Body Radiotherapy: An Exploratory Analysis of Phase 1 Trials
D. M. Rosenberg, L. Connor, M. Korpics, R. Katipally +4 more
2022International Journal of Radiation Oncology, Biology, Physics1 citations
Semantic Scholar
Evaluation of Initial Metastatic Tumor Location and Radiation Response to Determine Outcomes in Patients Who Received Combination Stereotactic Body Radiotherapy and Immunotherapy for NSCLC.
K. Pointer, R. Katipally, C. Bestvina, A. Juloori +6 more
2021International Journal of Radiation Oncology, Biology, Physics1 citations Open access
Semantic Scholar
RO01.01 Prospective Evaluation of Ipilimumab and Nivolumab in Patients with Non-Small Cell Lung Cancer Brain Metastasis
A. Juloori, C. Bestvina, S. Pitroda, K. Pointer +5 more
20211 citations Open access
Semantic Scholar
867P A phase I trial of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma
A. Rosenberg, N. Agrawal, Z. Gooi, E. Blair +8 more
2021Annals of Oncology1 citations Open access
Semantic Scholar
Feasibility Of Next-Generation Genomic Sequencing To Identify Prognostic Biomarkers Of Chemoradiation Response For Salivary Gland Malignancies
J. Hara, D. Biton, B. Onderdonk, S. Gutiontov +9 more
20201 citations
Semantic Scholar
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation
R. Philips, A. Mahajan, L. Estephan, S. Auger +24 more
2026Annals of Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Katipally×19
Invite
R. Katipally — researcher profile on SciRah
D. Haraf×18
Invite
D. Haraf — researcher profile on SciRah
E. Vokes×17
Invite
E. Vokes — researcher profile on SciRah
C. Bestvina×16
Invite
C. Bestvina — researcher profile on SciRah

×16

Invite

S. Pitroda — researcher profile on SciRah

Invite

S. Chmura — researcher profile on SciRah

Invite

A. Pearson — researcher profile on SciRah

Invite

E. Vokes — researcher profile on SciRah

A. Rosenberg×12

Invite

A. Rosenberg — researcher profile on SciRah

Invite

N. Agrawal — researcher profile on SciRah

Invite

Z. Gooi — researcher profile on SciRah

Invite

J. Cursio — researcher profile on SciRah